MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway

Background: Osteosarcoma is the most prevalent primary malignant bone tumor containing mesenchymal cells with poor prognosis. Being a hot spot of anti-tumor therapy researches, AKT/mammalian target of rapamycin (mTOR) signaling pathway could affect various cellular processes including transcription,...

Full description

Bibliographic Details
Main Authors: Dong Cao, Shanshan Ge, Mengchun Li
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Journal of Bone Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137422000021
_version_ 1828201730534277120
author Dong Cao
Shanshan Ge
Mengchun Li
author_facet Dong Cao
Shanshan Ge
Mengchun Li
author_sort Dong Cao
collection DOAJ
description Background: Osteosarcoma is the most prevalent primary malignant bone tumor containing mesenchymal cells with poor prognosis. Being a hot spot of anti-tumor therapy researches, AKT/mammalian target of rapamycin (mTOR) signaling pathway could affect various cellular processes including transcription, protein synthesis, apoptosis, autophagy and growth. Materials and methods: The levels of RNA and protein were detected by quantitative real-time polymerase chain reaction (q-PCR) and western blot analyses respectively. Functional assays were carried out to analyze the malignant phenotypes of osteosarcoma cells. RNA-binding protein immunoprecipitation (RIP), Co-immunoprecipitation (Co-IP), RNA pulldown, luciferase reporter and in vitro kinase assays were conducted to uncover the specific mechanism of microRNA-451a (miR-451a) in osteosarcoma cells. Results: Functionally, miR-451a represses the malignant progression of osteosarcoma. Mechanically, miR-451a could curb the AKT/mTOR pathway via 3-phosphoinositide dependent protein kinase 1 (PDPK1)-mediated phosphorylation modification. After the certification that YTH domain containing 1 (YTHDC1) regulates the m6A phosphorylation modification of PDPK1 mRNA, we further proved that miR-451a-mediated YTHDC1 stabilizes PDPK1 mRNA via m6A-dependent regulation. Conclusion: This study demonstrated that miR-451a regulates YTHDC1-mediated m6A methylation to activate the AKT/mTOR pathway, stimulating the malignancy of osteosarcoma.
first_indexed 2024-04-12T11:34:52Z
format Article
id doaj.art-f6b18f7ced694ef7a9786e66e565d576
institution Directory Open Access Journal
issn 2212-1374
language English
last_indexed 2024-04-12T11:34:52Z
publishDate 2022-04-01
publisher Elsevier
record_format Article
series Journal of Bone Oncology
spelling doaj.art-f6b18f7ced694ef7a9786e66e565d5762022-12-22T03:34:52ZengElsevierJournal of Bone Oncology2212-13742022-04-0133100412MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathwayDong Cao0Shanshan Ge1Mengchun Li2The Physical Examination Center, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, ChinaThe Physical Examination Center, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, ChinaDepartment of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, China; Corresponding author at: Department of Nuclear Medicine, First Hospital of Shanxi Medical University, No. 85 South Jiefang Road, Taiyuan 030001, Shanxi, China.Background: Osteosarcoma is the most prevalent primary malignant bone tumor containing mesenchymal cells with poor prognosis. Being a hot spot of anti-tumor therapy researches, AKT/mammalian target of rapamycin (mTOR) signaling pathway could affect various cellular processes including transcription, protein synthesis, apoptosis, autophagy and growth. Materials and methods: The levels of RNA and protein were detected by quantitative real-time polymerase chain reaction (q-PCR) and western blot analyses respectively. Functional assays were carried out to analyze the malignant phenotypes of osteosarcoma cells. RNA-binding protein immunoprecipitation (RIP), Co-immunoprecipitation (Co-IP), RNA pulldown, luciferase reporter and in vitro kinase assays were conducted to uncover the specific mechanism of microRNA-451a (miR-451a) in osteosarcoma cells. Results: Functionally, miR-451a represses the malignant progression of osteosarcoma. Mechanically, miR-451a could curb the AKT/mTOR pathway via 3-phosphoinositide dependent protein kinase 1 (PDPK1)-mediated phosphorylation modification. After the certification that YTH domain containing 1 (YTHDC1) regulates the m6A phosphorylation modification of PDPK1 mRNA, we further proved that miR-451a-mediated YTHDC1 stabilizes PDPK1 mRNA via m6A-dependent regulation. Conclusion: This study demonstrated that miR-451a regulates YTHDC1-mediated m6A methylation to activate the AKT/mTOR pathway, stimulating the malignancy of osteosarcoma.http://www.sciencedirect.com/science/article/pii/S2212137422000021OsteosarcomamiR-451aAKT/mTOR signaling pathwaym6A methylation
spellingShingle Dong Cao
Shanshan Ge
Mengchun Li
MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
Journal of Bone Oncology
Osteosarcoma
miR-451a
AKT/mTOR signaling pathway
m6A methylation
title MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
title_full MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
title_fullStr MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
title_full_unstemmed MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
title_short MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
title_sort mir 451a promotes cell growth migration and emt in osteosarcoma by regulating ythdc1 mediated m6a methylation to activate the akt mtor signaling pathway
topic Osteosarcoma
miR-451a
AKT/mTOR signaling pathway
m6A methylation
url http://www.sciencedirect.com/science/article/pii/S2212137422000021
work_keys_str_mv AT dongcao mir451apromotescellgrowthmigrationandemtinosteosarcomabyregulatingythdc1mediatedm6amethylationtoactivatetheaktmtorsignalingpathway
AT shanshange mir451apromotescellgrowthmigrationandemtinosteosarcomabyregulatingythdc1mediatedm6amethylationtoactivatetheaktmtorsignalingpathway
AT mengchunli mir451apromotescellgrowthmigrationandemtinosteosarcomabyregulatingythdc1mediatedm6amethylationtoactivatetheaktmtorsignalingpathway